Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes

DiabetologiaPublished Epigenome-wide association study

Authors' conclusion

The current study detected 11 loci associated with DKD progression, identifying methylation changes predictive of early-stage DKD progression in type 1 diabetes for the first time. Future research is needed to establish prognostic DNA methylation markers for DKD progression.

Study context

Population
Individuals with T1D from the Finnish Diabetic Nephropathy Study cohort; baseline blood DNA methylation
Participants
403 vs 372
Exposure
Early-stage progression vs Late-stage progression
  • Early-stage progressionn = 403
  • Late-stage progressionn = 372
Outcome
DKD progression: eGFR decrease to <60 ml/min per 1.73 m² (early-stage) and ESKD (late-stage)
Methodological detailsprospective cohort, replication in two T1D cohorts and public EWAS summary statistics, integration with genetic and proteomic data
  • Prospective cohort
  • Replication in two T1D cohorts and public EWAS summary statistics
  • Integration with genetic and proteomic data

Main finding

As reported in the abstract

Methylation sites associated with DKD progression
Methylation sites associated with diabetic kidney disease (DKD) progression (p<9.4 × 10-8)
11
Lead end-stage kidney disease (ESKD) risk locus cg17944885 (chr19p13.2)
p=2.6 × 10-17

Observational data: associations, not effects.

Further findings

Proteomic analysis of cis proteins

cg14999724 methylation associated with PRG3 and PRG2; cg12272104 with BSG, FSTL3 and PALM; UK Biobank data show associations of these proteins with severe kidney endpoints

Prediction of early-stage DKD progression

Survival models with methylation markers plus clinical risk factors significantly improved identification of individuals at risk of early-stage progression

Original publication

Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes. Diabetologia. Published 22 January 2026. doi:10.1007/s00125-025-06661-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.